Cargando…

In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease

The pandemic that started in Wuhan (China) in 2019 has caused a large number of deaths, and infected people around the world due to the absence of effective therapy against coronavirus 2 of the severe acute respiratory syndrome (SARS-CoV-2). Viral maturation requires the activity of the main viral p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yañez, Osvaldo, Osorio, Manuel Isaías, Uriarte, Eugenio, Areche, Carlos, Tiznado, William, Pérez-Donoso, José M., García-Beltrán, Olimpo, González-Nilo, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893092/ https://www.ncbi.nlm.nih.gov/pubmed/33614592 http://dx.doi.org/10.3389/fchem.2020.595097

Ejemplares similares

Theobroma cacao L. compounds: Theoretical study and molecular modeling as inhibitors of main SARS-CoV-2 protease
por: Yañez, Osvaldo, et al.
Publicado: (2021)

Coumarin-Chalcone Hybrids as Inhibitors of MAO-B: Biological Activity and In Silico Studies
por: Moya-Alvarado, Guillermo, et al.
Publicado: (2021)

Theoretical Study of the Antioxidant Activity of Quercetin Oxidation Products
por: Vásquez-Espinal, Alejandro, et al.
Publicado: (2019)

Search for Novel Potent Inhibitors of the SARS-CoV-2 Papain-like Enzyme: A Computational Biochemistry Approach
por: Osorio, Manuel I., et al.
Publicado: (2022)

Study of Coumarin-Resveratrol Hybrids as Potent Antioxidant Compounds
por: Matos, Maria J., et al.
Publicado: (2015)

In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
por: Muhtar, Eldar, et al.
Publicado: (2021)

3-Phenylcoumarin
por: Matos, Maria J., et al.
Publicado: (2012)

Biosystem Analysis of the Hypoxia Inducible Domain Family Member 2A: Implications in Cancer Biology
por: Salazar, Celia, et al.
Publicado: (2020)

Several coumarin derivatives and their Pd(ii) complexes as potential inhibitors of the main protease of SARS-CoV-2, an in silico approach
por: Milenković, Dejan A., et al.
Publicado: (2020)

Isolation and In Silico SARS-CoV-2 Main Protease Inhibition Potential of Jusan Coumarin, a New Dicoumarin from Artemisia glauca
por: Suleimen, Yerlan M., et al.
Publicado: (2022)

In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2
por: Abdizadeh, Rahman, et al.
Publicado: (2021)

Trending Topics on Coumarin and Its Derivatives in 2020
por: Carneiro, Aitor, et al.
Publicado: (2021)

In silico analysis of Phyllanthus amarus phytochemicals as potent drugs against SARS-CoV-2 main protease
por: Murthy, T.P. Krishna, et al.
Publicado: (2021)

Rational design of potent anti-COVID-19 main protease drugs: An extensive multi-spectrum in silico approach
por: Ahmad, Sajjad, et al.
Publicado: (2021)

3-(4-Methoxybenzoyl)-6-nitrocoumarin
por: Vazquez-Rodriguez, Saleta, et al.
Publicado: (2013)

In Silico Discovery of Novel Potent Antioxidants on the Basis of Pulvinic Acid and Coumarine Derivatives and Their Experimental Evaluation
por: Martinčič, Rok, et al.
Publicado: (2015)

Identification of alkaloids from Justicia adhatoda as potent SARS CoV-2 main protease inhibitors: An in silico perspective
por: Ghosh, Rajesh, et al.
Publicado: (2021)

COVID-19: In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2
por: Oubahmane, Mehdi, et al.
Publicado: (2021)

Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: In silico study
por: Kumar, Nitish, et al.
Publicado: (2021)

Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives
por: Matos, Maria João, et al.
Publicado: (2022)

A highly sensitive and selective chemosensor for Pb(2+) based on quinoline–coumarin
por: Meng, Xianjiao, et al.
Publicado: (2018)

Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
por: Lin, Yuxi, et al.
Publicado: (2021)

Potent and biostable inhibitors of the main protease of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2022)

Curcumin–Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders
por: Quezada, Elías, et al.
Publicado: (2021)

An in-silico evaluation of COVID-19 main protease with clinically approved drugs
por: Tachoua, Wafa, et al.
Publicado: (2020)

Statins and the COVID-19 main protease: in silico evidence on direct interaction
por: Reiner, Željko, et al.
Publicado: (2020)

UHPLC-MS Metabolomic Fingerprinting, Antioxidant, and Enzyme Inhibition Activities of Himantormia lugubris from Antarctica
por: Areche, Carlos, et al.
Publicado: (2022)

Flavonoid compounds of buah merah (Pandanus conoideus Lamk) as a potent SARS-CoV-2 main protease inhibitor: in silico approach
por: Umar, Abd. Kakhar
Publicado: (2021)

An in-silico investigation of potential natural polyphenols for the targeting of COVID main protease inhibitor
por: Aljarba, Nada H., et al.
Publicado: (2022)

In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease
por: Abdelrady, Yousef A, et al.
Publicado: (2023)

Coumarin-Based Fluorescent Probes for Dual Recognition of Copper(II) and Iron(III) Ions and Their Application in Bio-Imaging
por: García-Beltrán, Olimpo, et al.
Publicado: (2014)

Structural Factors That Determine the Activity of the Xenobiotic Reductase B Enzyme from Pseudomonas putida on Nitroaromatic Compounds
por: Osorio, Manuel I., et al.
Publicado: (2022)

Molecular modeling and simulations of some antiviral drugs, benzylisoquinoline alkaloid, and coumarin molecules to investigate the effects on Mpro main viral protease inhibition
por: Mir, Showkat Ahmad, et al.
Publicado: (2023)

Blocking oestradiol synthesis pathways with potent and selective coumarin derivatives
por: Niinivehmas, Sanna, et al.
Publicado: (2018)

Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (M(pro)): DFT, QSAR, molecular docking, and in silico toxicity analysis
por: Mohapatra, Ranjan K., et al.
Publicado: (2021)

The interaction of alpha-mangostin and its derivatives against main protease enzyme in COVID-19 using in silico methods
por: Hidayat, Syahrul, et al.
Publicado: (2021)

In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease
por: Mostafa, Islam, et al.
Publicado: (2021)

Acridone Alkaloids: In-Silico Investigation Against SARS-CoV-2 Main Protease
por: Oderinlo, Ogunyemi Olajide, et al.
Publicado: (2022)

Adenosine Receptor Ligands: Coumarin–Chalcone Hybrids as Modulating Agents on the Activity of hARs
por: Vazquez-Rodriguez, Saleta, et al.
Publicado: (2020)

In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus
por: Eleftheriou, Phaedra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u5dgipltc00nh06tn03ipr5kuq